For a substantial proportion of patients with deep venous thrombosis (DVT), current treatment strategies are suboptimal and new treatment options are needed. Especially for the group of patients who are at the highest risk for post-thrombotic syndrome, new treatment modalities such as catheter-directed thrombolysis and additional stenting are being investigated. With current clinical studies addressing new technical options, the medical management of patients following these interventions deserves attention. The duration of anticoagulant treatment following surgical or radiological interventions for DVT seems not to be influenced by the presence of a venous stent. According to recent ACCP 2012 guidelines the anticoagulant management in pati...
Venous thromboembolism, a frequent and severe disease, has clinically important early and late compl...
Three-month anticoagulation is recommended to treat provoked or first distal deep-vein thrombosis (D...
Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unkno...
For a substantial proportion of patients with deep venous thrombosis (DVT), current treatment strate...
The current approach for deciding the duration of vitamin K antagonist (VKA) treatment after an epis...
International audienceMost patients who present with deep vein thrombosis (DVT) can be treated with ...
Once anticoagulation is stopped, the risk of recurrent venous thromboembolism (VTE) over years after...
Treatment of acute deep vein thrombosis and pulmo-nary embolism-often denominated together as venous...
Treatment of acute deep vein thrombosis and pulmonary embolism-often denominated together as venous ...
The risk of recurrent venous thromboembolism (VTE) approaches 40 per cent of all patients after 10 y...
Randomized controlled trials have shown that patients with venous thromboembolism benefit from a min...
The post-thrombotic syndrome (PTS) is the major chronic sequel of deep vein thrombosis (DVT) of the ...
The impact of residual vein thrombosis (RVT) on the long-term outcome of patients with deep vein thr...
Background: Finding the optimal duration of anticoagulant treatment following an acute event of deep...
Residual vein thrombosis (RVT) indicates a prothrombotic state and is useful for evaluating the opti...
Venous thromboembolism, a frequent and severe disease, has clinically important early and late compl...
Three-month anticoagulation is recommended to treat provoked or first distal deep-vein thrombosis (D...
Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unkno...
For a substantial proportion of patients with deep venous thrombosis (DVT), current treatment strate...
The current approach for deciding the duration of vitamin K antagonist (VKA) treatment after an epis...
International audienceMost patients who present with deep vein thrombosis (DVT) can be treated with ...
Once anticoagulation is stopped, the risk of recurrent venous thromboembolism (VTE) over years after...
Treatment of acute deep vein thrombosis and pulmo-nary embolism-often denominated together as venous...
Treatment of acute deep vein thrombosis and pulmonary embolism-often denominated together as venous ...
The risk of recurrent venous thromboembolism (VTE) approaches 40 per cent of all patients after 10 y...
Randomized controlled trials have shown that patients with venous thromboembolism benefit from a min...
The post-thrombotic syndrome (PTS) is the major chronic sequel of deep vein thrombosis (DVT) of the ...
The impact of residual vein thrombosis (RVT) on the long-term outcome of patients with deep vein thr...
Background: Finding the optimal duration of anticoagulant treatment following an acute event of deep...
Residual vein thrombosis (RVT) indicates a prothrombotic state and is useful for evaluating the opti...
Venous thromboembolism, a frequent and severe disease, has clinically important early and late compl...
Three-month anticoagulation is recommended to treat provoked or first distal deep-vein thrombosis (D...
Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unkno...